About Us

Based in Silicon Valley, PROCEPT BioRobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. With an initial focus on benign prostatic hyperplasia (BPH), PROCEPT has developed Aquablation® therapy, a novel and disruptive treatment for enlarged prostate. The company’s first product, the AquaBeam® System, is the world’s first surgical robot providing autonomous tissue removal for the safe and effective treatment of BPH, independent of prostate anatomy or surgeon experience.

Team

1/ 8
  • Nikolai Aljuri, Ph.D.
  • Nikolai Aljuri, Ph.D.
Nikolai Aljuri, Ph.D., Co-Founder, President, and CEO
Co-founder, President and CEO

Nikolai Aljuri, Ph.D.

Dr. Aljuri is the principal architect of the AquaBeam System and its core Aquablation technology. Prior to the formation of PROCEPT he invented and developed the Chartis collateral ventilation assessment technology at Pulmonx that facilitated an effective therapeutic treatment for emphysema. At the NASA Center for Quantitative Cardiovascular Physiology and Data Analysis he worked on the physiologic implications for astronauts in the manned space mission to Mars. Dr. Aljuri has a Dipl.-Ing. in electrical engineering from the Universität Fridericiana zu Karlsruhe (KIT) in Germany and holds a Ph.D. in Medical Physics from the Harvard-MIT Division of Health Science and Technology at the Massachusetts Institute of Technology (MIT).
Surag Mantri, Senior VP, Research and Development
Sr. Vice President, Research and Development

Surag Mantri

Mr. Mantri has over 15 years of medical device experience which includes design and development, clinical validation, EU/FDA regulatory approval, commercialization, sales/marketing support, and post-commercial technical & clinical training. Prior to his tenure at PROCEPT, he managed and provided engineering solutions to a diverse set of projects including embolic protection, insulin delivery, continuous glucose monitor, reconstructive surgical, cardiovascular, lung and ophthalmic implants, endoscopic RF toolset, diagnostic system for lung function, fall-detection wearable, and robotic-assisted surgical devices. Mr. Mantri received a B.S. degree in Computer Science, M.S. in Bioinformatics, and M.S. in Bioengineering from Stanford University. He has over 25 patent and patent applications.
Bijesh Chandran VP, Regulatory Affairs, Quality Assurance & Clinical Operations
Vice President, Regulatory Affairs, Quality Assurance & Clinical Operations

Bijesh Chandran

Mr. Chandran brings 20 years of combined experience in quality assurance, regulatory affairs, test engineering, and program management.  He has a passion for bringing new and disruptive technologies to market by building compliant yet flexible RAQA infrastructure based on product and business for both US and Int’l markets.  Mr. Chandran has held quality and regulatory leadership positions at numerous medical device companies, including Stryker Endoscopy, Siemens Ultrasound, Arthrocare Corporation (Smith & Nephew), InSound Medical (Phonak), myoscience & R2 Dermatology.  He has a BE in Electronics and Communications Engineering from India and has an MS in Electrical Engineering from University of Texas at Austin and is also a Stanford Certified Project Manager (SCPM).
Daniel Cher, MD, VP Quality, Regulatory Affairs, and Biostatistics
Vice President, Medical Affairs

Daniel Cher, MD

Dr. Cher is an internist with over 20 years of clinical research experience in a variety of medical device applications. He develops clinical and regulatory strategies, designs and leads clinical trials, and conducts statistical analysis. Most recently, he served as VP of Clinical Affairs at SI-BONE and VP of Clinical and Regulatory Affairs at Chestnut Medical Technologies. Educated at Stanford and Yale Universities, Dr. Cher pursued his internal medicine residency at University of Wisconsin, and California Pacific Medical Center. He gained additional training in general internal medicine and research methods at Stanford University and the Palo Alto VA Hospital.
Matthew Salkeld, VP Sales and Marketing
Vice President, Sales and Marketing

Matthew Salkeld

Mr. Salkeld has 20 years medical device industry experience in Sales and Sales Management, Strategy and Product Marketing, Clinical Market Development, and Finance. Prior to PROCEPT, Mr. Salkeld spent 7 years at Acclarent, acquired by Johnson & Johnson in 2010 where he was a member of the executive team with responsibilities including US Sales, WW Marketing, & Professional Education. Previous roles included extensive experience in the cardiovascular area with executive Sales & Marketing positions at Cierra, Inc. and Vascular Architects, as well as a variety of roles at Guidant, which was acquired by Abbott Vascular. Prior to Guidant, Mr. Salkeld was a Manager at Ernst & Young, LLP. Mr. Salkeld holds a BS in Commerce and an MBA from Santa Clara University.
Kevin Staid, VP Engineering
Vice President, Engineering

Kevin Staid

Mr. Staid has extensive experience in the conception, development, and manufacture of medical devices. He was founder and innovator at HydroCision developing the core pumping and fluid jet technology, and worked extensively with medical leaders conceiving and fabricating surgical fluid jet devices for wound care, arthroscopy, and spine. Mr. Staid engaged with leaders in the fields exploring markets and developing devices in cosmetics, gynecology, urology, and neurosurgery. Previous roles include engineering and operations positions at CR Bard, American Surgical Technology, and Johnson & Johnson. Mr. Staid studied Mechanical Engineering at University of Massachusetts - Lowell and received a B.S. Management from Lesley University. He has many patents and patent applications.
Eric Steuben, VP Operations
Vice President, Operations

Eric Steuben

Mr. Steuben is an energetic leader with over 25 years of progressive achievements from hands-on engineering to executive management. He has broad corporate experience ranging from high-growth start-ups and world-leading corporations. Eric has successfully transferred manufacturing operations offshore to China, Mexico, Pakistan, Dubai, and Costa Rica. Prior to joining PROCEPT, he held executive leadership roles in manufacturing, operations, regulatory affairs and quality assurance with Clarity Medical Systems, Asante Solutions, Align Technology and MicroDental Laboratories. He started his career at Varian Medical. Eric holds both a BS degree in Mechanical Engineering and a Masters degree in Business Administration from Santa Clara University.
Barry Templin, VP Clinical Affairs
Vice President, Market Readiness and Clinical Affairs

Barry Templin

Mr. Templin has over 15 years of experience in clinical research, engineering, and market development, primarily within the medical device industry. Most recently, he served as the VP of Clinical Research, Engineering, and Therapy Development for CardioKinetix. Prior to CardioKinetix, Mr. Templin was the Global Clinical Program Director for Abbott Vascular. He also led the landmark vulnerable plaque natural history study, PROSPECT. Prior to that role, Mr. Templin held engineering roles with GE Aircraft Engines and Guidant, and then clinical positions with Guidant (that was later acquired by Abbott). Mr. Templin holds a BS in Mechanical Engineering and minor in Economics from Rose-Hulman Institute of Technology and an MBA from Duke.

1/ 16
  • Nikolai Aljuri, Ph.D.
  • Nikolai Aljuri, Ph.D.
Nikolai Aljuri, Ph.D., Co-Founder, President, and CEO
Co-founder, President and CEO

Nikolai Aljuri, Ph.D.

Dr. Aljuri is the principal architect of the AquaBeam System and its core Aquablation technology. Prior to the formation of PROCEPT he invented and developed the Chartis collateral ventilation assessment technology at Pulmonx that facilitated an effective therapeutic treatment for emphysema. At the NASA Center for Quantitative Cardiovascular Physiology and Data Analysis he worked on the physiologic implications for astronauts in the manned space mission to Mars. Dr. Aljuri has a Dipl.-Ing. in electrical engineering from the Universität Fridericiana zu Karlsruhe (KIT) in Germany and holds a Ph.D. in Medical Physics from the Harvard-MIT Division of Health Science and Technology at the Massachusetts Institute of Technology (MIT).
Dark blue background

Nikolai Aljuri, Ph.D.

Dr. Aljuri is the principal architect of the AquaBeam System and its core Aquablation technology. Prior to the formation of PROCEPT he invented and developed the Chartis collateral ventilation assessment technology at Pulmonx that facilitated an effective therapeutic treatment for emphysema. At the NASA Center for Quantitative Cardiovascular Physiology and Data Analysis he worked on the physiologic implications for astronauts in the manned space mission to Mars. Dr. Aljuri has a Dipl.-Ing. in electrical engineering from the Universität Fridericiana zu Karlsruhe (KIT) in Germany and holds a Ph.D. in Medical Physics from the Harvard-MIT Division of Health Science and Technology at the Massachusetts Institute of Technology (MIT).
Surag Mantri, Senior VP, Research and Development
Sr. Vice President, Research and Development

Surag Mantri

Mr. Mantri has over 15 years of medical device experience which includes design and development, clinical validation, EU/FDA regulatory approval, commercialization, sales/marketing support, and post-commercial technical & clinical training. Prior to his tenure at PROCEPT, he managed and provided engineering solutions to a diverse set of projects including embolic protection, insulin delivery, continuous glucose monitor, reconstructive surgical, cardiovascular, lung and ophthalmic implants, endoscopic RF toolset, diagnostic system for lung function, fall-detection wearable, and robotic-assisted surgical devices. Mr. Mantri received a B.S. degree in Computer Science, M.S. in Bioinformatics, and M.S. in Bioengineering from Stanford University. He has over 25 patent and patent applications.
Bijesh Chandran VP, Regulatory Affairs, Quality Assurance & Clinical Operations
Vice President, Regulatory Affairs, Quality Assurance & Clinical Operations

Bijesh Chandran

Mr. Chandran brings 20 years of combined experience in quality assurance, regulatory affairs, test engineering, and program management.  He has a passion for bringing new and disruptive technologies to market by building compliant yet flexible RAQA infrastructure based on product and business for both US and Int’l markets.  Mr. Chandran has held quality and regulatory leadership positions at numerous medical device companies, including Stryker Endoscopy, Siemens Ultrasound, Arthrocare Corporation (Smith & Nephew), InSound Medical (Phonak), myoscience & R2 Dermatology.  He has a BE in Electronics and Communications Engineering from India and has an MS in Electrical Engineering from University of Texas at Austin and is also a Stanford Certified Project Manager (SCPM).
Daniel Cher, MD, VP Quality, Regulatory Affairs, and Biostatistics
Vice President, Medical Affairs

Daniel Cher, MD

Dr. Cher is an internist with over 20 years of clinical research experience in a variety of medical device applications. He develops clinical and regulatory strategies, designs and leads clinical trials, and conducts statistical analysis. Most recently, he served as VP of Clinical Affairs at SI-BONE and VP of Clinical and Regulatory Affairs at Chestnut Medical Technologies. Educated at Stanford and Yale Universities, Dr. Cher pursued his internal medicine residency at University of Wisconsin, and California Pacific Medical Center. He gained additional training in general internal medicine and research methods at Stanford University and the Palo Alto VA Hospital.
Matthew Salkeld, VP Sales and Marketing
Vice President, Sales and Marketing

Matthew Salkeld

Mr. Salkeld has 20 years medical device industry experience in Sales and Sales Management, Strategy and Product Marketing, Clinical Market Development, and Finance. Prior to PROCEPT, Mr. Salkeld spent 7 years at Acclarent, acquired by Johnson & Johnson in 2010 where he was a member of the executive team with responsibilities including US Sales, WW Marketing, & Professional Education. Previous roles included extensive experience in the cardiovascular area with executive Sales & Marketing positions at Cierra, Inc. and Vascular Architects, as well as a variety of roles at Guidant, which was acquired by Abbott Vascular. Prior to Guidant, Mr. Salkeld was a Manager at Ernst & Young, LLP. Mr. Salkeld holds a BS in Commerce and an MBA from Santa Clara University.
Kevin Staid, VP Engineering
Vice President, Engineering

Kevin Staid

Mr. Staid has extensive experience in the conception, development, and manufacture of medical devices. He was founder and innovator at HydroCision developing the core pumping and fluid jet technology, and worked extensively with medical leaders conceiving and fabricating surgical fluid jet devices for wound care, arthroscopy, and spine. Mr. Staid engaged with leaders in the fields exploring markets and developing devices in cosmetics, gynecology, urology, and neurosurgery. Previous roles include engineering and operations positions at CR Bard, American Surgical Technology, and Johnson & Johnson. Mr. Staid studied Mechanical Engineering at University of Massachusetts - Lowell and received a B.S. Management from Lesley University. He has many patents and patent applications.
Eric Steuben, VP Operations
Vice President, Operations

Eric Steuben

Mr. Steuben is an energetic leader with over 25 years of progressive achievements from hands-on engineering to executive management. He has broad corporate experience ranging from high-growth start-ups and world-leading corporations. Eric has successfully transferred manufacturing operations offshore to China, Mexico, Pakistan, Dubai, and Costa Rica. Prior to joining PROCEPT, he held executive leadership roles in manufacturing, operations, regulatory affairs and quality assurance with Clarity Medical Systems, Asante Solutions, Align Technology and MicroDental Laboratories. He started his career at Varian Medical. Eric holds both a BS degree in Mechanical Engineering and a Masters degree in Business Administration from Santa Clara University.
Barry Templin, VP Clinical Affairs
Vice President, Market Readiness and Clinical Affairs

Barry Templin

Mr. Templin has over 15 years of experience in clinical research, engineering, and market development, primarily within the medical device industry. Most recently, he served as the VP of Clinical Research, Engineering, and Therapy Development for CardioKinetix. Prior to CardioKinetix, Mr. Templin was the Global Clinical Program Director for Abbott Vascular. He also led the landmark vulnerable plaque natural history study, PROSPECT. Prior to that role, Mr. Templin held engineering roles with GE Aircraft Engines and Guidant, and then clinical positions with Guidant (that was later acquired by Abbott). Mr. Templin holds a BS in Mechanical Engineering and minor in Economics from Rose-Hulman Institute of Technology and an MBA from Duke.
Dark blue background
Co-founder and Chairman of the Board

Rodney Perkins, M.D.

Dr. Perkins is an internationally known ear surgeon, the founder of the California Ear Institute at Stanford and a successful serial medical device entrepreneur. He is the founder of three public companies: Collagen, Laserscope, and ReSound, and was chairman of the latter two. Dr. Perkins is or was founder or co-founder and chairman of Cohesion, Novacept, Pulmonx, Sound ID, Surgrx, Define, Minerva, Iogyn and Soundhawk. Dr. Perkins received the Phoenix Hall of Fame Innovation Award and the Lifetime Achievement Award from Medical Futures, a British organization that fosters innovation in medicine. He is a graduate of the Indiana University School of Medicine where he recently received the Distinguished Medical Alumnus Award. Dr. Perkins is a Clinical Professor of Surgery at Stanford and holds over 40 patents.
Dark blue background
Director

Antal Desai

Mr. Desai is a partner at CPMG, Inc. CPMG is an investment firm that employs a concentrated, value-oriented approach to investing in publicly traded and private operating companies. Prior to joining CPMG’s predecessor, Cardinal Investment Company, Mr. Desai worked as an analyst at WhiteHorse Capital Partners, L.P. He currently serves on the Board of Directors of PROCEPT BioRobotics Corporation, Theatro Labs, Inc., ESN Venture Holdings LLC, Lifeblue Incorporated, and Travel Research Advisors LLC. Mr. Desai holds a B.S. and an M.B.A. from The Wharton School at the University of Pennsylvania.
Dark blue background

William Facteau

William Facteau is a medical device executive with 25 years’ experience.  He is currently the President and CEO of Earlens Corp, which is focused on transforming the hearing aid industry with its novel and proprietary light-based technology. Prior to joining Earlens, Mr. Facteau served as President and CEO of Acclarent, the company that created Balloon Sinuplasty which was ultimately acquired by JNJ for $800M.  Mr. Facteau has served as a Board Director on a number of successfully acquired ventures including Acclarent, Neotract, CVI, Cabachon, and ExploraMed.
Dark blue background
Director

Thomas Krummel, M.D.

Dr. Krummel is the Surgeon-in-Chief at Lucile Packard Children’s Hospital and Chairman of the Surgery Department at the Stanford University School of Medicine, He is the founder of the Surgical Innovation Program at Stanford, and Co-Director of the Stanford Biodesign Program which teaches innovation and implementation of new surgical technologies. The program has spawned 35 start-ups which have received more than $300 million in follow-on financing. Dr. Krummel has lectured throughout the world and is author or co-author of over 300 publications, chapters, abstracts and books. He is on the board of the Fogarty Innovation Institute and has served on the board of directors or scientific advisory boards of 15 medical device start-ups.
Dark blue background
Director

Frederic Moll, M.D.

Dr. Moll is the founder, Chairman and CEO of Auris Surgical Robotics. Prior to Auris he was co-founder of Hansen Medical, Restoration Robotics and founder and first CEO of Intuitive Surgical, the world leader in surgical robotics, and a major player in urology. Dr. Moll was a co-founder of Origin Medsystems, and served as the Medical Director of Guidant's Surgical Device Division. Early in his career he founded Endotherapeutics, a pioneering company in laparoscopic surgical technology. Dr. Moll holds a B.A. degree from the University of California at Berkeley, an M.S. degree in management from Stanford University, and an M.D. degree from the University of Washington.
Dark blue background
Director

Eric Reuter

Mr. Reuter is a medical device executive with nearly 30 years of product design and development, project management, and executive management experience in both public and private companies. Most recently, he was president, CEO of Satiety, a private, venture-backed company focused on developing a minimally invasive solution for obesity. Prior to Satiety, he was president, CEO of Laserscope, a leading company in urology with the Green Light laser. Also, Mr. Reuter served as the independent director at Insound. In his early career he was the Project Engineer in the B-Factor high energy research project at the Stanford Linear Accelerator Center and an engineer at Siemens Medical Systems. Mr. Reuter received his BS degree in Mechanical and Materials engineering from UC Davis.
Dark blue background
Director

Colby Wood

Mr. Wood is a Portfolio Manager and Research Analyst for Oechsle International Advisors in London where he is responsible for medical technology investments globally. Prior to this current position, he was with Freeman & Company, a boutique M&A advisory firm focused on the financial services industry. Earlier in his career Mr. Wood was actively involved as an investor, asset gatherer and business development executive for early stage companies in financial services and medical technology sectors. Mr. Wood holds a B.A. from the University of Delaware and an MBA in Finance and Entrepreneurship from the F.W. Olin Graduate of Business at Babson College.

1/ 8
  • Nikolai Aljuri, Ph.D.
  • Nikolai Aljuri, Ph.D.
Dark blue background

Nikolai Aljuri, Ph.D.

Dr. Aljuri is the principal architect of the AquaBeam System and its core Aquablation technology. Prior to the formation of PROCEPT he invented and developed the Chartis collateral ventilation assessment technology at Pulmonx that facilitated an effective therapeutic treatment for emphysema. At the NASA Center for Quantitative Cardiovascular Physiology and Data Analysis he worked on the physiologic implications for astronauts in the manned space mission to Mars. Dr. Aljuri has a Dipl.-Ing. in electrical engineering from the Universität Fridericiana zu Karlsruhe (KIT) in Germany and holds a Ph.D. in Medical Physics from the Harvard-MIT Division of Health Science and Technology at the Massachusetts Institute of Technology (MIT).
Dark blue background
Co-founder and Chairman of the Board

Rodney Perkins, M.D.

Dr. Perkins is an internationally known ear surgeon, the founder of the California Ear Institute at Stanford and a successful serial medical device entrepreneur. He is the founder of three public companies: Collagen, Laserscope, and ReSound, and was chairman of the latter two. Dr. Perkins is or was founder or co-founder and chairman of Cohesion, Novacept, Pulmonx, Sound ID, Surgrx, Define, Minerva, Iogyn and Soundhawk. Dr. Perkins received the Phoenix Hall of Fame Innovation Award and the Lifetime Achievement Award from Medical Futures, a British organization that fosters innovation in medicine. He is a graduate of the Indiana University School of Medicine where he recently received the Distinguished Medical Alumnus Award. Dr. Perkins is a Clinical Professor of Surgery at Stanford and holds over 40 patents.
Dark blue background
Director

Antal Desai

Mr. Desai is a partner at CPMG, Inc. CPMG is an investment firm that employs a concentrated, value-oriented approach to investing in publicly traded and private operating companies. Prior to joining CPMG’s predecessor, Cardinal Investment Company, Mr. Desai worked as an analyst at WhiteHorse Capital Partners, L.P. He currently serves on the Board of Directors of PROCEPT BioRobotics Corporation, Theatro Labs, Inc., ESN Venture Holdings LLC, Lifeblue Incorporated, and Travel Research Advisors LLC. Mr. Desai holds a B.S. and an M.B.A. from The Wharton School at the University of Pennsylvania.
Dark blue background

William Facteau

William Facteau is a medical device executive with 25 years’ experience.  He is currently the President and CEO of Earlens Corp, which is focused on transforming the hearing aid industry with its novel and proprietary light-based technology. Prior to joining Earlens, Mr. Facteau served as President and CEO of Acclarent, the company that created Balloon Sinuplasty which was ultimately acquired by JNJ for $800M.  Mr. Facteau has served as a Board Director on a number of successfully acquired ventures including Acclarent, Neotract, CVI, Cabachon, and ExploraMed.
Dark blue background
Director

Thomas Krummel, M.D.

Dr. Krummel is the Surgeon-in-Chief at Lucile Packard Children’s Hospital and Chairman of the Surgery Department at the Stanford University School of Medicine, He is the founder of the Surgical Innovation Program at Stanford, and Co-Director of the Stanford Biodesign Program which teaches innovation and implementation of new surgical technologies. The program has spawned 35 start-ups which have received more than $300 million in follow-on financing. Dr. Krummel has lectured throughout the world and is author or co-author of over 300 publications, chapters, abstracts and books. He is on the board of the Fogarty Innovation Institute and has served on the board of directors or scientific advisory boards of 15 medical device start-ups.
Dark blue background
Director

Frederic Moll, M.D.

Dr. Moll is the founder, Chairman and CEO of Auris Surgical Robotics. Prior to Auris he was co-founder of Hansen Medical, Restoration Robotics and founder and first CEO of Intuitive Surgical, the world leader in surgical robotics, and a major player in urology. Dr. Moll was a co-founder of Origin Medsystems, and served as the Medical Director of Guidant's Surgical Device Division. Early in his career he founded Endotherapeutics, a pioneering company in laparoscopic surgical technology. Dr. Moll holds a B.A. degree from the University of California at Berkeley, an M.S. degree in management from Stanford University, and an M.D. degree from the University of Washington.
Dark blue background
Director

Eric Reuter

Mr. Reuter is a medical device executive with nearly 30 years of product design and development, project management, and executive management experience in both public and private companies. Most recently, he was president, CEO of Satiety, a private, venture-backed company focused on developing a minimally invasive solution for obesity. Prior to Satiety, he was president, CEO of Laserscope, a leading company in urology with the Green Light laser. Also, Mr. Reuter served as the independent director at Insound. In his early career he was the Project Engineer in the B-Factor high energy research project at the Stanford Linear Accelerator Center and an engineer at Siemens Medical Systems. Mr. Reuter received his BS degree in Mechanical and Materials engineering from UC Davis.
Dark blue background
Director

Colby Wood

Mr. Wood is a Portfolio Manager and Research Analyst for Oechsle International Advisors in London where he is responsible for medical technology investments globally. Prior to this current position, he was with Freeman & Company, a boutique M&A advisory firm focused on the financial services industry. Earlier in his career Mr. Wood was actively involved as an investor, asset gatherer and business development executive for early stage companies in financial services and medical technology sectors. Mr. Wood holds a B.A. from the University of Delaware and an MBA in Finance and Entrepreneurship from the F.W. Olin Graduate of Business at Babson College.

1/ 16
  • Nikolai Aljuri, Ph.D.
  • Nikolai Aljuri, Ph.D.
Nikolai Aljuri, Ph.D., Co-Founder, President, and CEO
Co-founder, President and CEO

Nikolai Aljuri, Ph.D.

Dr. Aljuri is the principal architect of the AquaBeam System and its core Aquablation technology. Prior to the formation of PROCEPT he invented and developed the Chartis collateral ventilation assessment technology at Pulmonx that facilitated an effective therapeutic treatment for emphysema. At the NASA Center for Quantitative Cardiovascular Physiology and Data Analysis he worked on the physiologic implications for astronauts in the manned space mission to Mars. Dr. Aljuri has a Dipl.-Ing. in electrical engineering from the Universität Fridericiana zu Karlsruhe (KIT) in Germany and holds a Ph.D. in Medical Physics from the Harvard-MIT Division of Health Science and Technology at the Massachusetts Institute of Technology (MIT).
Dark blue background

Nikolai Aljuri, Ph.D.

Dr. Aljuri is the principal architect of the AquaBeam System and its core Aquablation technology. Prior to the formation of PROCEPT he invented and developed the Chartis collateral ventilation assessment technology at Pulmonx that facilitated an effective therapeutic treatment for emphysema. At the NASA Center for Quantitative Cardiovascular Physiology and Data Analysis he worked on the physiologic implications for astronauts in the manned space mission to Mars. Dr. Aljuri has a Dipl.-Ing. in electrical engineering from the Universität Fridericiana zu Karlsruhe (KIT) in Germany and holds a Ph.D. in Medical Physics from the Harvard-MIT Division of Health Science and Technology at the Massachusetts Institute of Technology (MIT).
Surag Mantri, Senior VP, Research and Development
Sr. Vice President, Research and Development

Surag Mantri

Mr. Mantri has over 15 years of medical device experience which includes design and development, clinical validation, EU/FDA regulatory approval, commercialization, sales/marketing support, and post-commercial technical & clinical training. Prior to his tenure at PROCEPT, he managed and provided engineering solutions to a diverse set of projects including embolic protection, insulin delivery, continuous glucose monitor, reconstructive surgical, cardiovascular, lung and ophthalmic implants, endoscopic RF toolset, diagnostic system for lung function, fall-detection wearable, and robotic-assisted surgical devices. Mr. Mantri received a B.S. degree in Computer Science, M.S. in Bioinformatics, and M.S. in Bioengineering from Stanford University. He has over 25 patent and patent applications.
Bijesh Chandran VP, Regulatory Affairs, Quality Assurance & Clinical Operations
Vice President, Regulatory Affairs, Quality Assurance & Clinical Operations

Bijesh Chandran

Mr. Chandran brings 20 years of combined experience in quality assurance, regulatory affairs, test engineering, and program management.  He has a passion for bringing new and disruptive technologies to market by building compliant yet flexible RAQA infrastructure based on product and business for both US and Int’l markets.  Mr. Chandran has held quality and regulatory leadership positions at numerous medical device companies, including Stryker Endoscopy, Siemens Ultrasound, Arthrocare Corporation (Smith & Nephew), InSound Medical (Phonak), myoscience & R2 Dermatology.  He has a BE in Electronics and Communications Engineering from India and has an MS in Electrical Engineering from University of Texas at Austin and is also a Stanford Certified Project Manager (SCPM).
Daniel Cher, MD, VP Quality, Regulatory Affairs, and Biostatistics
Vice President, Medical Affairs

Daniel Cher, MD

Dr. Cher is an internist with over 20 years of clinical research experience in a variety of medical device applications. He develops clinical and regulatory strategies, designs and leads clinical trials, and conducts statistical analysis. Most recently, he served as VP of Clinical Affairs at SI-BONE and VP of Clinical and Regulatory Affairs at Chestnut Medical Technologies. Educated at Stanford and Yale Universities, Dr. Cher pursued his internal medicine residency at University of Wisconsin, and California Pacific Medical Center. He gained additional training in general internal medicine and research methods at Stanford University and the Palo Alto VA Hospital.
Matthew Salkeld, VP Sales and Marketing
Vice President, Sales and Marketing

Matthew Salkeld

Mr. Salkeld has 20 years medical device industry experience in Sales and Sales Management, Strategy and Product Marketing, Clinical Market Development, and Finance. Prior to PROCEPT, Mr. Salkeld spent 7 years at Acclarent, acquired by Johnson & Johnson in 2010 where he was a member of the executive team with responsibilities including US Sales, WW Marketing, & Professional Education. Previous roles included extensive experience in the cardiovascular area with executive Sales & Marketing positions at Cierra, Inc. and Vascular Architects, as well as a variety of roles at Guidant, which was acquired by Abbott Vascular. Prior to Guidant, Mr. Salkeld was a Manager at Ernst & Young, LLP. Mr. Salkeld holds a BS in Commerce and an MBA from Santa Clara University.
Kevin Staid, VP Engineering
Vice President, Engineering

Kevin Staid

Mr. Staid has extensive experience in the conception, development, and manufacture of medical devices. He was founder and innovator at HydroCision developing the core pumping and fluid jet technology, and worked extensively with medical leaders conceiving and fabricating surgical fluid jet devices for wound care, arthroscopy, and spine. Mr. Staid engaged with leaders in the fields exploring markets and developing devices in cosmetics, gynecology, urology, and neurosurgery. Previous roles include engineering and operations positions at CR Bard, American Surgical Technology, and Johnson & Johnson. Mr. Staid studied Mechanical Engineering at University of Massachusetts - Lowell and received a B.S. Management from Lesley University. He has many patents and patent applications.
Eric Steuben, VP Operations
Vice President, Operations

Eric Steuben

Mr. Steuben is an energetic leader with over 25 years of progressive achievements from hands-on engineering to executive management. He has broad corporate experience ranging from high-growth start-ups and world-leading corporations. Eric has successfully transferred manufacturing operations offshore to China, Mexico, Pakistan, Dubai, and Costa Rica. Prior to joining PROCEPT, he held executive leadership roles in manufacturing, operations, regulatory affairs and quality assurance with Clarity Medical Systems, Asante Solutions, Align Technology and MicroDental Laboratories. He started his career at Varian Medical. Eric holds both a BS degree in Mechanical Engineering and a Masters degree in Business Administration from Santa Clara University.
Barry Templin, VP Clinical Affairs
Vice President, Market Readiness and Clinical Affairs

Barry Templin

Mr. Templin has over 15 years of experience in clinical research, engineering, and market development, primarily within the medical device industry. Most recently, he served as the VP of Clinical Research, Engineering, and Therapy Development for CardioKinetix. Prior to CardioKinetix, Mr. Templin was the Global Clinical Program Director for Abbott Vascular. He also led the landmark vulnerable plaque natural history study, PROSPECT. Prior to that role, Mr. Templin held engineering roles with GE Aircraft Engines and Guidant, and then clinical positions with Guidant (that was later acquired by Abbott). Mr. Templin holds a BS in Mechanical Engineering and minor in Economics from Rose-Hulman Institute of Technology and an MBA from Duke.
Dark blue background
Co-founder and Chairman of the Board

Rodney Perkins, M.D.

Dr. Perkins is an internationally known ear surgeon, the founder of the California Ear Institute at Stanford and a successful serial medical device entrepreneur. He is the founder of three public companies: Collagen, Laserscope, and ReSound, and was chairman of the latter two. Dr. Perkins is or was founder or co-founder and chairman of Cohesion, Novacept, Pulmonx, Sound ID, Surgrx, Define, Minerva, Iogyn and Soundhawk. Dr. Perkins received the Phoenix Hall of Fame Innovation Award and the Lifetime Achievement Award from Medical Futures, a British organization that fosters innovation in medicine. He is a graduate of the Indiana University School of Medicine where he recently received the Distinguished Medical Alumnus Award. Dr. Perkins is a Clinical Professor of Surgery at Stanford and holds over 40 patents.
Dark blue background
Director

Antal Desai

Mr. Desai is a partner at CPMG, Inc. CPMG is an investment firm that employs a concentrated, value-oriented approach to investing in publicly traded and private operating companies. Prior to joining CPMG’s predecessor, Cardinal Investment Company, Mr. Desai worked as an analyst at WhiteHorse Capital Partners, L.P. He currently serves on the Board of Directors of PROCEPT BioRobotics Corporation, Theatro Labs, Inc., ESN Venture Holdings LLC, Lifeblue Incorporated, and Travel Research Advisors LLC. Mr. Desai holds a B.S. and an M.B.A. from The Wharton School at the University of Pennsylvania.
Dark blue background

William Facteau

William Facteau is a medical device executive with 25 years’ experience.  He is currently the President and CEO of Earlens Corp, which is focused on transforming the hearing aid industry with its novel and proprietary light-based technology. Prior to joining Earlens, Mr. Facteau served as President and CEO of Acclarent, the company that created Balloon Sinuplasty which was ultimately acquired by JNJ for $800M.  Mr. Facteau has served as a Board Director on a number of successfully acquired ventures including Acclarent, Neotract, CVI, Cabachon, and ExploraMed.
Dark blue background
Director

Thomas Krummel, M.D.

Dr. Krummel is the Surgeon-in-Chief at Lucile Packard Children’s Hospital and Chairman of the Surgery Department at the Stanford University School of Medicine, He is the founder of the Surgical Innovation Program at Stanford, and Co-Director of the Stanford Biodesign Program which teaches innovation and implementation of new surgical technologies. The program has spawned 35 start-ups which have received more than $300 million in follow-on financing. Dr. Krummel has lectured throughout the world and is author or co-author of over 300 publications, chapters, abstracts and books. He is on the board of the Fogarty Innovation Institute and has served on the board of directors or scientific advisory boards of 15 medical device start-ups.
Dark blue background
Director

Frederic Moll, M.D.

Dr. Moll is the founder, Chairman and CEO of Auris Surgical Robotics. Prior to Auris he was co-founder of Hansen Medical, Restoration Robotics and founder and first CEO of Intuitive Surgical, the world leader in surgical robotics, and a major player in urology. Dr. Moll was a co-founder of Origin Medsystems, and served as the Medical Director of Guidant's Surgical Device Division. Early in his career he founded Endotherapeutics, a pioneering company in laparoscopic surgical technology. Dr. Moll holds a B.A. degree from the University of California at Berkeley, an M.S. degree in management from Stanford University, and an M.D. degree from the University of Washington.
Dark blue background
Director

Eric Reuter

Mr. Reuter is a medical device executive with nearly 30 years of product design and development, project management, and executive management experience in both public and private companies. Most recently, he was president, CEO of Satiety, a private, venture-backed company focused on developing a minimally invasive solution for obesity. Prior to Satiety, he was president, CEO of Laserscope, a leading company in urology with the Green Light laser. Also, Mr. Reuter served as the independent director at Insound. In his early career he was the Project Engineer in the B-Factor high energy research project at the Stanford Linear Accelerator Center and an engineer at Siemens Medical Systems. Mr. Reuter received his BS degree in Mechanical and Materials engineering from UC Davis.
Dark blue background
Director

Colby Wood

Mr. Wood is a Portfolio Manager and Research Analyst for Oechsle International Advisors in London where he is responsible for medical technology investments globally. Prior to this current position, he was with Freeman & Company, a boutique M&A advisory firm focused on the financial services industry. Earlier in his career Mr. Wood was actively involved as an investor, asset gatherer and business development executive for early stage companies in financial services and medical technology sectors. Mr. Wood holds a B.A. from the University of Delaware and an MBA in Finance and Entrepreneurship from the F.W. Olin Graduate of Business at Babson College.

Careers & Culture

PROCEPT is transforming patient care by pioneering autonomous surgical robotics in the field of urology.

 

  • We believe in teamwork, trust, respect, collaboration and a can-do-attitude.
  • We encourage out-of-the-box thinking and challenging the status quo.
  • We know how to work hard and have fun both in the office and outside.
HEALTH
  • Medical
  • Dental
  • Vision
  • FSA
  • Wellness programs
FINANCIAL
  • 401k retirement plan
  • Stock options
  • Long term disability insurance
  • Travel accident insurance on business travel
LIFESTYLE
  • On-site gym
  • Commuter discounts
  • Student loan discounts
  • Pet insurance discounts
  • Free snacks and drinks
  • Ping pong in the office
SOCIAL
  • Team building events
  • BBQ’s
  • Ice cream socials
  • Happy hour gatherings

…and much more

Challenge yourself by joining our dynamic team developing surgical robots that are designed to transform patient care.

POSITIONS

We do not accept resumes from staffing agencies or search firms unless a valid search agreement is in place with the agency for a specific position.

Join the Team

To apply to one of the positions listed, please
click below and include a copy of your resume.

Join the Team

To apply to one of the positions listed, please
click below and include a copy of your resume.

PROCEPT is transforming patient care by pioneering autonomous surgical robotics in the field of urology.

 

  • We believe in teamwork, trust, respect, collaboration and a can-do-attitude.
  • We encourage out-of-the-box thinking and challenging the status quo.
  • We know how to work hard and have fun both in the office and outside.
HEALTH
  • Medical
  • Dental
  • Vision
  • FSA
  • Wellness programs
FINANCIAL
  • 401k retirement plan
  • Stock options
  • Long term disability insurance
  • Travel accident insurance on business travel
LIFESTYLE
  • On-site gym
  • Commuter discounts
  • Student loan discounts
  • Pet insurance discounts
  • Free snacks and drinks
  • Ping pong in the office
SOCIAL
  • Team building events
  • BBQ’s
  • Ice cream socials
  • Happy hour gatherings

…and much more

Challenge yourself by joining our dynamic team developing surgical robots that are designed to transform patient care.

POSITIONS

We do not accept resumes from staffing agencies or search firms unless a valid search agreement is in place with the agency for a specific position.

Contact

 

 

Headquarters
Customer Service

900 Island Drive, Suite 210
Redwood Shores, CA 94065
Phone: +1 (650) 232-7222
eFax: +1 (888) 285-3777

Contact

 

 

Headquarters
Customer Service

900 Island Drive, Suite 210
Redwood Shores, CA 94065
Phone: +1 (650) 232-7222
eFax: +1 (888) 285-3777